Pim-2 Transgene Induces Lymphoid Tumors, Exhibiting Potent Synergy With C-Myc

Oncogene - United Kingdom
doi 10.1038/sj.onc.1201288
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Bromodomain Containing 2 (BRD2); BRD3; BRD4; C-Myc (MYC)

Science-Business eXchange
2011English

Molecular Characterizations of Nop16 in Murine Mammary Tumors With Varying Levels of C-Myc

Transgenic Research
GeneticsCrop ScienceAnimal ScienceZoologyBiotechnologyAgronomy
2011English

Expression Profile of microRNAs in C-Myc Induced Mouse Mammary Tumors

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Dominant-Negative TAK1 Induces C-Myc and G0 Exit in Liver

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2001English

Expression of C-Myc and Mutation of the KRAS Gene in Patients With Ovarian Mucinous Tumors

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Inhibition of C-Myc Expression Induces Apoptosis of WEHI 231 Murine B Cells.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1996English

TNF Induces the Production of Type 2 Cytokines in Human Group 2 Innate Lymphoid Cells

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Frequent Amplification of C-Myc in Ground Squirrel Liver Tumors Associated With Past or Ongoing Infection With a Hepadnavirus.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Identification of a Phenanthrene Derivative as a Potent Anticancer Drug With Pim Kinase Inhibitory Activity

Cancer Science
Cancer ResearchMedicineOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy